SEARCH

SEARCH BY CITATION

References

  • ACC/AHA (2005). 2005 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112 (24 Suppl.): IV1203.
  • Acevedo M (1994). Effect of acetyl choline on ion transport in sheep tracheal epithelium. Pflugers Arch 427: 543546.
  • Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS et al. (1994). Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272: 14971505.
  • Aquilina AT, Hall WJ, Douglas RG Jr, Utell MJ (1980). Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis 122: 310.
  • Ayala LE, Ahmed T (1989). Is there loss of protective muscarinic receptor mechanism in asthma? Chest 96: 12851291.
  • Baker DG, Don HF, Brown JK (1992). Direct measurement of acetylcholine release in guinea pig trachea. Am J Physiol 263 (1 Pt 1): L142L147.
  • Bany U, Gajewski M, Ksiezopolska-Pietrzak K, Jozwicka M, Klimczak E, Ryzewski J et al. (1999). Expression of mRNA encoding muscarinic receptor subtypes in neutrophils of patients with rheumatoid arthritis. Ann NY Acad Sci 876: 301304.
  • Barnes PJ (1993). Muscarinic receptor subtypes in airways. Eur Respir J 6: 328331.
  • Barnes PJ (2001). Tiotropium bromide. Expert Opin Investig Drugs 10: 733740.
  • Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B (1995). Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci 56: 853859.
  • Blaber LC, Fryer AD, Maclagan J (1985). Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br J Pharmacol 86: 723728.
  • Borson DB, Chin RA, Davis B, Nadel JA (1980). Adrenergic and cholinergic nerves mediate fluid secretion from tracheal glands of ferrets. J Appl Physiol 49: 10271031.
  • Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H et al. (2007). Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30: 653661.
  • Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S (2003). Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58: 399404.
  • Buels KS, Jacoby DB, Fryer AD (2010). Selectively blocking M3 muscarinc receptors at the time of antigen challenge prevents airway hyperreactivity 24 h later in guinea pigs. Am J Respir Crit Care Med 181 (1_MeetingAbstracts): A3974.
  • Buhling F, Lieder N, Kuhlmann UC, Waldburg N, Welte T (2007). Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 101: 23862394.
  • Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL et al., Jr (2002). A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217224.
  • Casarosa P, Bouyssou T, Germeyer S, Schnapp A, Gantner F, Pieper M (2009). Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. J Pharmacol Exp Ther 330: 660668.
  • Caulfield MP, Birdsall NJ (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279290.
  • Cavanaugh MJ, Cooper DM (1976). Inhaled atropine sulfate: dose-response characteristics. Am Rev Respir Dis 114: 517524.
  • Cazzola M, Matera MG (2008). Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol 155: 291299.
  • Chen WY, Brenner AM, Weiser PC, Chai H (1981). Atropine and exercise-induced bronchoconstriction. Chest 79: 651656.
  • Costello RW, Evans CM, Yost BL, Belmonte KE, Gleich GJ, Jacoby DB et al. (1999). Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. Am J Physiol 276 (5 Pt 1): L709L714.
  • Cugell DW (1986). Clinical pharmacology and toxicology of ipratropium bromide. Am J Med 81: 1822.
  • Cydulka RK, Emerman CL (1994). Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma. Ann Emerg Med 23: 270274.
  • Cydulka RK, Emerman CL (1995). Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 25: 470473.
  • Davies DS (1975). Pharmacokinetics of inhaled substances. Postgrad Med J 51 (7 Suppl.): 6975.
  • Disse B, Reichl R, Speck G, Traunecker W, Ludwig Rominger KL, Hammer R (1993). Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci 52: 537544.
  • Disse B, Speck GA, Rominger KL, Witek TJ, Jr, Hammer R (1999). Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64: 457464.
  • Donohue JF, Menjoge S, Kesten S (2003). Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med 97: 10141020.
  • Ebell B (1937). The Papyrus Ebers. Levin Munksgaard: Copenhagen.
  • Ellul-Micallef R (1997). History of bronchial asthma. In: Barnes PJ, Grunstein MM, Leff AR (eds). Asthma. Lippincott Raven: Philadelphia, PA, pp. 925.
  • Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA (1976). Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 113: 131139.
  • Ensing K, de Zeeuw RA, Nossent GD, Koeter GH, Cornelissen PJ (1989). Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration. Eur J Clin Pharmacol 36: 189194.
  • EPR-3 (2007). Expert Panel Report 3 (EPR-3): guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 120 (5 Suppl.): S94S138.
  • Evans CM, Fryer AD, Jacoby DB, Gleich GJ, Costello RW (1997). Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 100: 22542262.
  • Faulkner D, Fryer AD, Maclagan J (1986). Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 88: 181187.
  • Fernandes LB, Fryer AD, Hirshman CA (1992). M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 262: 119126.
  • Fryer AD, Jacoby DB (1991). Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 102: 267271.
  • Fryer AD, Maclagan J (1984). Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 83: 973978.
  • Fryer AD, Maclagan J (1987). Pancuronium and gallamine are antagonists for pre- and post-junctional muscarinic receptors in the guinea-pig lung. Naunyn Schmiedebergs Arch Pharmacol 335: 367371.
  • Fryer AD, Elbon CL, Kim AL, Xiao HQ, Levey AI, Jacoby DB (1996). Cultures of airway parasympathetic nerves express functional M2 muscarinic receptors. Am J Respir Cell Mol Biol 15: 716725.
  • Gavalda A, Miralpeix M, Ramos I, Otal R, Carreno C, Vinals M et al. (2009). Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. J Pharmacol Exp Ther 331: 740751.
  • Goodman E (2010). Historical Contributions to the Human Toxicology of Atropine : Behavioral Effects of High Doses of Atropine and Military Uses of Atropine to Produce Intoxication, 1st edn. Eximdyne: Wentzville, MO.
  • Goodman LS, Gilman A, Brunton LL, Lazo JS, Parker KL (2006). Goodman & Gilman's the Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill: New York.
  • Gross NJ (1988). Ipratropium bromide. N Engl J Med 319: 486494.
  • Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF (1989). Dose-response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis 139: 11881191.
  • Gunther W, Kamburoff PL (1974). The bronchodilator effect of a new anticholinergic drug, Sch 1000. Curr Med Res Opin 2: 281287.
  • Haddad EB, Mak JC, Barnes PJ (1994). Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. Mol Pharmacol 45: 899907.
  • Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG (1999). Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. Br J Pharmacol 127: 413420.
  • Hansel TT, Neighbour H, Erin EM, Tan AJ, Tennant RC, Maus JG et al. (2005). Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma. Chest 128: 19741979.
  • Hinderling PH, Gundert-Remy U, Schmidlin O (1985a). Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. I: pharmacokinetics. J Pharm Sci 74: 703710.
  • Hinderling PH, Gundert-Remy U, Schmidlin O, Heinzel G (1985b). Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. II: pharmacodynamics. J Pharm Sci 74: 711717.
  • Holtzman MJ, Sheller JR, Dimeo M, Nadel JA, Boushey HA (1980). Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis 122: 1725.
  • Holtzman MJ, McNamara MP, Sheppard D, Fabbri LM, Hahn HL, Graf PD et al. (1983). Intravenous versus inhaled atropine for inhibiting bronchoconstrictor responses in dogs. J Appl Physiol 54: 134139.
  • Ichinose M, Fujimoto T, Fukuchi Y (2010). Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med 104: 228236.
  • Joos GF, Schelfhout VJ, Pauwels RA, Kanniess F, Magnussen H, Lamarca R et al. (2010). Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respir Med 104: 865872.
  • Kalser SC (1971). The fate of atropine in man. Ann NY Acad Sci 179: 667683.
  • Klein MK, Haberberger RV, Hartmann P, Faulhammer P, Lips KS, Krain B et al. (2009). Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development. Eur Respir J 33: 11131121.
  • Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS et al., Jr (2000). Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (4 Pt 1): 11361142.
  • Lu S, Parekh DD, Kuznetsova O, Green SA, Tozzi CA, Reiss TF (2006). An oral selective M3 cholinergic receptor antagonist in COPD. Eur Respir J 28: 772780.
  • Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ (1995). Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Eur Respir J 8: 15061513.
  • Mak JC, Barnes PJ (1989). Muscarinic receptor subtypes in human and guinea pig lung. Eur J Pharmacol 164: 223230.
  • Marin MG, Davis B, Nadel JA (1976). Effect of acetylcholine on Cl- and Na+ fluxes across dog tracheal epithelium in vitro. Am J Physiol 231 (5 Pt. 1):15461549.
  • Minette PA, Barnes PJ (1988). Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J Appl Physiol 64: 25322537.
  • Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ (1989). A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 67: 24612465.
  • Mirakhur RK (1978). Comparative study of the effects of oral and i.m. atropine and hyoscine in volunteers. Br J Anaesth 50: 591598.
  • Nadel JA, Barnes PJ (1984). Autonomic regulation of the airways. Annu Rev Med 35: 451467.
  • van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C (2009). The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir Med 103: 2229.
  • Norman P (2006). Long-acting muscarinic M3 receptor antagonists. Expert Opin Ther Pat 16: 13151320.
  • O'Connor BJ, Towse LJ, Barnes PJ (1996). Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 154 (4 Pt 1): 876880.
  • Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1980). Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20: 237266.
  • Patacchini R, Bergamaschi M, Harrison S, Petrillo P, Gigli PM, Janni A et al. (2007). In vitro pharmacological profile of CHF 5407, a potent, long-acting and selective muscarinic M3 receptor antagonist. Eur Respir J 30: 25s26s.
  • Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M et al. (2007a). Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1). J Med Chem 50: 15711583.
  • Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E et al. (2007b). Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2). J Med Chem 50: 16931697.
  • Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT et al. (2010). Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma. N Engl J Med 363: 17151726.
  • Phillips JE, Hey JA, Corboz MR (2002). Effects of ion transport inhibitors on MCh-mediated secretion from porcine airway submucosal glands. J Appl Physiol 93: 873881.
  • Prat M, Fernandez D, Buil MA, Crespo MI, Casals G, Ferrer M et al. (2009). Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicy clo[2.2.2]octane bromide (aclidinium bromide). J Med Chem 52: 50765092.
  • Price D, Sharma A, Cerasoli F (2009). Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients. Expert Opin Drug Metab Toxicol 5: 417424.
  • Proakis AG, Harris GB (1978). Comparative penetration of glycopyrrolate and atropine across the blood – brain and placental barriers in anesthetized dogs. Anesthesiology 48: 339344.
  • Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532555.
  • Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N et al. (1987). Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82: 5964.
  • Reinheimer T, Baumgartner D, Hohle KD, Racke K, Wessler I (1997). Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi. Am J Respir Crit Care Med 156 (2 Pt 1): 389395.
  • Restrepo RD (2007). Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care 52: 833851.
  • Rodrigo GJ, Castro-Rodriguez JA (2005). Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60: 740746.
  • Rodrigo GJ, Rodrigo C (2000). First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 161: 18621868.
  • Roffel AF, Elzinga CR, Zaagsma J (1990). Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 3: 4751.
  • Ruffin RE, Fitzgerald JD, Rebuck AS (1977). A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J Allergy Clin Immunol 59: 136141.
  • Schelfhout VJ, Ferrer P, Jansat JM, Peris F, Gil EG, Pauwels RA et al. (2010a). Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study. Br J Clin Pharmacol 69: 458464.
  • Schelfhout VJ, Ferrer P, Jansat JM, Peris F, Gil EG, Pauwels RA et al. (2010b). Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study. Br J Clin Pharmacol 69: 458464.
  • Schultheis AJH (1992). The effect of ozone on inflammatory cell infiltration and airway hyperresponsiveness in the guinea pig lungThesis (Ph D). Johns Hopkins University, 1993.
  • Schultheis AH, Bassett DJ, Fryer AD (1994). Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function. J Appl Physiol 76: 10881097.
  • Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA (1982). Dose-dependent inhibition of cold air-induced bronchoconstriction by atropine. J Appl Physiol 53: 169174.
  • Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA (1983). Effect of route of atropine delivery on bronchospasm from cold air and methacholine. J Appl Physiol 54: 130133.
  • Sorkness R, Clough JJ, Castleman WL, Lemanske RF, Jr (1994). Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am J Respir Crit Care Med 150: 2834.
  • Stoodley RG, Aaron SD, Dales RE (1999). The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 34: 818.
  • Swinney DC (2004). Biochemical mechanisms of drug action: what does it take for success? Nat Rev Drug Discov 3: 801808.
  • Takahashi T, Belvisi MG, Patel H, Ward JK, Tadjkarimi S, Yacoub MH et al. (1994). Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways. Am J Respir Crit Care Med 150 (6 Pt 1): 16401645.
  • Tashkin DP, Ashutosh K, Bleecker ER, Britt EJ, Cugell DW, Cummiskey JM et al. (1986). Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study. Am J Med 81 (5, Suppl. 1):8190.
  • Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S et al. (2008). A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 15431554.
  • Verbout NG, Lorton JK, Jacoby DB, Fryer A (2006). A functional role for muscarinic receptors on eosinophils in the airways. Proc Am Thorac Soc 3: A587.
  • Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L et al. (2002). Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 19: 209216.
  • Vincken W, Bantje T, Middle MV, Gerken F, Moonen D (2004). Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat((R)) Soft Misttrade mark Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma. Clin Drug Investig 24: 1728.
  • Ward MJ, Fentem PH, Smith WH, Davies D (1981). Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed) 282: 598600.
  • Wellstein A, Pitschner HF (1988). Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors. Naunyn Schmiedebergs Arch Pharmacol 338: 1927.
  • Wessler IK, Kirkpatrick CJ (2001). The Non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 14: 423434.
  • WHO (2010). WHO Model Lists of Essential Medicines Vol. 2010.
  • Yost BL, Gleich GJ, Fryer AD (1999). Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein. J Appl Physiol 87: 12721278.